http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113354713-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 |
| filingDate | 2021-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113354713-B |
| titleOfInvention | A kind of polypeptide and its application in the preparation of anti-platelet aggregation medicine |
| abstract | The invention discloses an anti-platelet aggregation polypeptide A11, which belongs to the field of medicine and biotechnology. The polypeptide A11 of the present invention is composed of 12 amino acids, has the sequence of the polypeptide of SEQ ID NO: 1, the molecular weight is 1262.24, and the sequence is Ser-Ile-Ser-Ser-Asn-Asn-Ser-Asn-Pro-Val-Glu- Asp. The polypeptide is not limited to inhibiting thrombin-induced platelet aggregation, and can be used to explore the effect and related functions of the polypeptide and other platelet activators (collagen, arachidonic acid, ADP, epinephrine, ristocetin, etc.) on platelets effects and can also be used to monitor existing antiplatelet therapy. |
| priorityDate | 2021-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.